Advocates prescribe more expansive pharma lawsuits
Antitrust academics and enforcers are encouraging the US competition agencies to look beyond overlapping products when reviewing pharmaceutical mergers.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10